Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-19-017856
Filing Date
2019-10-02
Accepted
2019-10-02 18:07:44
Documents
2
Period of Report
2019-10-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 form3.html 3  
1 FORM 3 form3.xml 3 2837
2 EXHIBIT 24 ex24.htm EX-24 9789
  Complete submission text file 0001140361-19-017856.txt   13992
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Issuer) CIK: 0001781983 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address
Attar Eyal C. (Reporting) CIK: 0001789076 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39069 | Film No.: 191133581